Cost Effectiveness of Treatments for Inflammatory Bowel Disease

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.5, 2011-05, pp. : 387-401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model

By Kreck Simon Klaus Jochen

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 311-328

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of Treatments for Inflammatory Bowel Disease

By Stein R.B.

Drug Safety, Vol. 23, Iss. 5, 2000-11 ,pp. : 429-448

Adis International

Access to resources Recommend Favorite

Inflammatory bowel disease: drugs cost $US7 million/year in Sweden

Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Modelling the Cost Effectiveness of Treatments for Parkinson's Disease: A Methodological Review

By Dams Judith

PharmacoEconomics, Vol. 29, Iss. 12, 2011-12 ,pp. : 1025-1049

Adis International

Access to resources Recommend Favorite

Inflammatory Bowel Disease in the Elderly

By > Pardi Darrell S.

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 617-624

Adis International

Access to resources Recommend Favorite